# A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis Patients

> **NCT02405780** · PHASE3 · COMPLETED · sponsor: **Fujifilm Kyowa Kirin Biologics Co., Ltd.** · enrollment: 645 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** FKB327
- **DRUG:** Humira®

## Key facts

- **NCT ID:** NCT02405780
- **Lead sponsor:** Fujifilm Kyowa Kirin Biologics Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-10
- **Primary completion:** 2018-01-18
- **Final completion:** 2018-01-18
- **Target enrollment:** 645 (ACTUAL)
- **Last updated:** 2019-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02405780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02405780, "A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02405780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*